Skip to main content
MedPathMedPath Home
Clinical Trials/NCT05570357
NCT05570357
Completed
Not Applicable

The Effects of Berberine and Cinnamon Supplementation on Diabetes Mangement

National Nutrition and Food Technology Institute1 site in 1 country44 target enrollmentJuly 1, 2022
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsDiabetes

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Diabetes
Sponsor
National Nutrition and Food Technology Institute
Enrollment
44
Locations
1
Primary Endpoint
HbA1C
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

In this randomized clinical trial, patients with diabetes will be randomly assigned to receive either Berberine, and Cinnamon supplements or placebo for 12 weeks. Then the glycemic characteristics will be compared in two groups.

Registry
clinicaltrials.gov
Start Date
July 1, 2022
End Date
February 10, 2023
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
National Nutrition and Food Technology Institute
Responsible Party
Principal Investigator
Principal Investigator

Dr Azita Hekmatdoost

Prof.

National Nutrition and Food Technology Institute

Eligibility Criteria

Inclusion Criteria

  • •Age 30-70 years
  • •Diagnosed type-2 diabetes mellitus (based on American Diabetes Association criteria)

Exclusion Criteria

  • •Patients with an allergy to berberine /cinamon
  • •Lactation, pregnancy
  • •Patients with any malignancy
  • •Patients with unrelated chronic illness
  • •Patients with cardiac, liver or respiratory failure

Outcomes

Primary Outcomes

HbA1C

Time Frame: 0 and 12th week

HbA1C change from baseline

Secondary Outcomes

  • CRP(0 and 12th week)
  • Lipid profile(0 and 12th week)
  • Anthropometric measurements(0 and 12th week)
  • Fasting blood sugar(0 and 12th week)
  • Blood Pressure(0 and 12th week)

Study Sites (1)

Loading locations...

Similar Trials

Not yet recruiting
Phase 4
Effects Of Berberine Plus Inulin On Diabetes Care in Patients With LADAType 1 Diabetes MellitusAutoimmune Diabetes
NCT04698330Second Xiangya Hospital of Central South University240
Completed
Phase 3
Randomized Controlled Clinical Trial of Cinnamon to Lower Hemoglobin A1cDiabetes
NCT00445354Eglin AFB Regional Hospital109
Completed
Phase 1
Therapeutic Effects of Berberine in Patients With Type 2 DiabetesType 2 Diabetes
NCT00425009Shanghai Jiao Tong University School of Medicine70
Completed
Phase 2
Berberine as Adjuvant Treatment for Schizophrenia PatientsSchizophreniaSchizophrenia Spectrum and Other Psychotic DisordersMetabolic Syndrome x
NCT02983188The University of Hong Kong113
Completed
Not Applicable
To Assess the Efficacy of Investigational Product on the Neuropathic Pain in Individuals Suffering From Type II Diabetes Mellitus.Diabetic NeuropathiesInsomnia Due to Medical Condition
NCT04504305Vedic Lifesciences Pvt. Ltd.64